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ABSTRACT OF THE DISSERTATION

Veterans of the 1st Persian Gulf War:
A Study of Medically Unexplained Symptom Models
by
Alexis Heman Collins
Doctor of Philosophy, Graduate Program in Psychology
Loma Linda University, August 2010
Dr. Kendal Boyd, Chairperson

In 1990-1991, shortly after the Persian Gulf War, a number of veterans began
complaining about a wide range of symptoms, the most common of which were; fatigue,
headache, sleep disturbance, low mood, and memory loss. These symptoms were similar
to those experienced by individuals with Medically Unexplained Illnesses such as
Chronic Fatigue Syndrome, Fibromyalgia, Irritable Bowel Syndrome, Multiple Chemical
Sensitivity, and Somatoform Disorders. Utilizing structural equation modeling and data
gathered from the Gulf War Veterans Health Questionnaire, this study attempted to
determine whether symptoms experienced by veterans were best explained as individual
items, discrete illnesses, or as a conglomeration of symptoms (i.e. Gulf War Illness).
Three models were proposed: a single factor, a five factor, or a second order model, and
run in EQS. Results indicate a strong fit for the second order model indicating the
presence Gulf War Illness as a separate, unifying concept that best accounts for
symptoms experienced by veterans of the Persian Gulf War. Treatment
recommendations and future considerations are discussed.

ix

Introduction

Medically unexplained illnesses (MUI) are the most common disorder seen in
primary care situations (Kroenke et al, 1997). In fact, they account for one in five new
consultations in primary care (Hartman et ah, 2004). Medically unexplained symptoms
or somatization disorders have been defined multiple ways. De Gucht and Maes (2006),
found that medically unexplained symptoms are typically viewed in one of three ways: as
a somatic expression of a psychiatric disorder, as a somatization disorder, or as a
functional somatic syndrome. A functional somatic symptom has been defined as a
cluster of symptoms that, “after appropriate medical assessment, cannot be explained in
terms of a conventionally defined medical disease (Wessely, Nimnuan & Sharpe, 1999, p.
936). A somatization disorder is characterized “by the presence of multiple somatic
symptoms, referring to different organ systems” (De Gucht and Maes, 2006). Sykes
(2005) notes that whether a symptom is characterized as either mental or physical in
nature can have practical implications on the treatment options. Whether the symptoms
are believed to be mental or physical in nature determines what treatment a patient will
receive as well as who will provide treatment. Regardless of whether MUI’s are
psychosocially or biochemically based, they have been chronicled throughout history.

History
Hysteria was recognized by the early Greeks and Egyptians and was long thought
to exclusively affect women (Johnson, 2008). Early theories characterized hysteria as
being caused by a “wandering womb” that moved about in a woman’s body. The term
hysteria, also known as conversion hysteria, involves an individual who has a physical
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symptom, such as blindness or a lack of feeling in a part of the body, for which there is
no apparent physical explanation for it (Benjafield, 1996). Perhaps the most famous case
of conversion hysteria dates back to the year 1880 involving a woman known as Anna O.,
who displayed paralysis of both legs and her right arm for which there was no apparent
physiological reason. Over time and through the use of psychological treatment her
symptoms improved. Today, the comorbidity between medically unexplained illnesses
and psychological disorders is well documented. Henningsen et al., (2003) in a metaanalytic review of medically unexplained symptoms found that four functional somatic
syndromes, namely irritable bowel syndrome (IBS), nonulcer dyspepsia, fibromyalgia
(FMS), and chronic fatigue syndrome (CFS) are related to both depression and anxiety.
Additionally they note that because medically unexplained symptoms may also arise
without concurrent depression and anxiety, it is not, therefore, possible to say that they
are merely the bodily expression of depression and anxiety.
Medically unexplained illnesses can be characterized by multiple symptoms,
significant suffering, and a disability that fails to show a consistent pathophysiology
(Barsky and Boms, 1999). Common symptoms in primary care may include fatigue,
pain, dizziness and a feeling of malaise. Furthermore, symptoms could also include
sexual-reproductive and gastrointestinal symptoms (Kroenke & Mangelsdorff, 1989).
Nimnuan, Hotopf, and Wessely (2001) found that medically unexplained symptoms were
associated with being female, younger, and currently employed. Nimnuan, Hotopf, and
Wessely (2001) also found that patients with medically unexplained symptoms were
more likely to attribute their illnesses to physical causes rather than lifestyle factors.
Nimnuan et. al., (2001) note that when the different symptoms become sufficiently
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prominent, they may be elevated to a syndrome. These syndromes include irritable bowel
syndrome and nonulcer dyspepsia, premenstrual syndrome and chronic pelvic pain,
fibromyalgia and chronic fatigue syndrome, and the more recent Gulf War Illness, among
others.
Just as with the interrelationship between psychiatric symptoms and MUI there is
some argument about whether there are, indeed, separate syndromes or whether there is
just one. Wessely, Nimnuan, and Sharpe (1999) have argued that there is substantial
overlap between the individual syndromes, and contend that the similarities between the
different syndromes outweigh the differences. They conclude that current definitions are
of little value and instead propose the use of a dimensional classification approach and
the use of a more broad-based approach. Nimnuan et al., (2001), using a principal
component analysis found that at the symptom level, the first factor accounted for nearly
30% of the total variance. Furthermore, the cumulative variance for all seven factors
used accounted for upwards of 60% of the total variance suggesting a sizeable amount of
variance could be explained by a single underlying factor.

Chronic Fatigue Syndrome
Chronic fatigue syndrome (CFS) “is an illness characterized by debilitating
fatigue along with cognitive, musculoskeletal, and sleep problems” (Afari & Buchwald,
2003 p. 230). It affects 400,000 to 900,000 adults in the United States and can cost up to
$9 billion in lost productivity per year (Reyes et al., 2003). Additionally at minimum
25% of those with CFS are either unemployed or are receiving disability due to the
illness. While CFS may affect any person regardless of age, race, ethnicity, or SES, the
typical person diagnosed with chronic fatigue syndrome is a woman in her 3O’s or 40’s
3

(Johnson, 2008). The prevalence of CFS in the working population has been found to be
as high as 3.6% (Huibers et al., 2004) although this number can vary due to the different
CFS definitions.
In 1988 the first case definition for CFS was developed (Holmes et al., 1988). A
history of 6 months of severe fatigue in a previously healthy person was required in order
to meet criteria. Severe fatigue was defined by a 50% reduction of daily activities. In
1994 the Centers for Disease Control and Prevention along with the National Institutes
for Health crafted a new definition (Fukuda et al., 1994). The 1994 case definition noted
that several conditions can coexist with CFS such as; hypothyroidism, Lyme disease,
asthma, syphilis, or fibromyalgia. Additionally the 1994 definition now had softened the
definition of fatigue so that while it still had to be new it had to result in a substantial
reduction of previous levels of functioning and left the definition of the word substantial
broad.
Pathophysiological explanations have included the presence of a chronic
infection. Indeed, for a time chronic fatigue was thought to represent a chronic form of
an Epstein-Barr infection although this was later ruled out (Natelson & Lange, 2002).
Other possible causal explanations have suggested that CFS is an immunologic reaction
or dysregulation triggered by an infection. Afari and Buchwald (2003) note that there is a
growing body of literature which suggests abnormal biological processes (e.g.,
abnormalities of the CNS and chronic activation of the immune system) may play a role
in CFS. Hyong et al., (2006), in a review of current literature found research supported
the notion of the involvement of the central nervous system, the serotonergic system, the
hypothalamid-pituitary-adrenal axis, the immune system, genetics, and psychological
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aspects as all playing a role in CFS. They conclude that while current studies appear to
support the notion of a discrete fatigue syndrome, the current case definition of CFS does
not define a single clinical entity. In an effort to clinically and empirically define CFS
using the 1994 CFS criteria, Reeves et al. (2005), found that those subjects who had been
empirically classified as CFS had significantly worse impairment, more sever fatigue,
more frequent and severe accompanying symptoms than those that did not meet criteria.
Furthermore, in 2004, Viner and Hotopf published a 30-year cohort study where they
found that chronic fatigue syndrome was predicted by the presence of a disabling illness
in childhood as well as rarely doing any exercise out of school at age 10. Additionally
those 10-year-old children who were reported by their mother as “never or hardly ever”
playing in sports in their free time had twice the risk of CFS in adulthood.
Current etiology calls for a model that incorporates not only the biological aspect
but also the psychological and cultural aspects of CFS. Adler (2004) proposes such a
model whereby he incorporates not only the “genetic endowments” as he calls them, but
also the experiences, life events, and personality features. Whether this biopsychosocial
model is correct remains to be seen but given what the research now demonstrate
regarding the multidimensionality of CFS it becomes more apparent that an inclusive
model is necessary.

Fibromyalgia
As with chronic fatigue syndrome and other medically unexplained syndromes,
doctors and researchers do not know exactly what causes fibromyalgia. Fibromyalgia, or
fibrositis as Dr. William Gowers called it in 1904, referred to regional pain syndromes
that were also associated with sleep disturbance and profound fatigue (Gowers, 1904).
5

This remained the case until Smythe and Moldofsky defined fibrositis in more clinical
terms including the presence of not only widespread pain but also multiple active tender
points (Ellis, 2008). The American College of Rheumatology lists diffuse soft tissue pain
of at least 3 months’ duration and pain on palpitation in at least 11 of 18 paired tender
points as the criteria for fibromyalgia. The pain is in response to stimuli not normally
considered painful. In addition to the general pain, a number of non-pain symptoms may
occur with fibromyalgia, including morning stiffness, cognitive problems, nonrestorative
sleep, depression, difficulty concentrating, dizziness, and anxiety. Furthermore,
symptoms are exacerbated by exertion, stress, lack of sleep, and weather changes
(Nampiaparampil & Shmerling, 2004).
Diagnosing fibromyalgia can be challenging. Due to the limited diagnostic
criteria available, diagnosis is typically one of exclusion rather than inclusion. Several
other rheumatic disorders may present as fibromyalgia initially such as polymyalgia
rheumatic and hypothyroidism. Typically blood tests are able to differentiate between
these diagnoses and fibromyalgia. Additionally, rheumatoid arthritis or lupus can mimic
fibromyalgia but these disorders also present with inflamed joints.
Fibromyalgia affects approximately 2-4% of people in the United States and over
5% of patients in general medical practice. Symptoms generally appear between the ages
of 20 to 55 and fibromyalgia affects women at a far higher rate than men. In fact, women
are more than nine times more likely to develop fibromyalgia than men (Berger et al.,
2007). Weir et al. (2006) found that patients with fibromyalgia were 2 to 7 times more
likely to be diagnosed with one or more of the examined comorbid conditions: CFS, IBS,
depression, anxiety, headache, and rheumatoid arthritis.
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The pathogenesis of fibromyalgia is not well known. Current research has shown
that individuals with fibromyalgia may have 2 to 3 times the levels of Substance P in
their spinal fluid as compared to an average person. Substance P is a pain modulator in
the cerebrospinal fluid and when combined with stress it may stimulate nerve growth and
promote abnormal pain perception (Nampiaparampil & Shmerling, 2004). Research into
the musculature of those suffering from fibromyalgia found no difference in force
generated or lactate produced during exercise. Additionally muscle pain after exertion
was similar between those with fibromyalgia and the control group (Hakkinen et al.,
2000). Research into the hypothalamic-pituitary-adrenal axis suggests that fibromyalgia
patients may have low adrenal responsiveness (Crofford et al., 1994).
Unlike other medically unexplained syndromes, the overlap between fibromyalgia
and other functional disorders such as CFS or IBS can be pronounced (Aaron &
Buchwald, 2001). Many patients with these other conditions may also have tender point
areas and the main difference between some patients who meet the criteria for CFS and
those who have fibromyalgia is the level of pain.

Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a functional disorder of the intestinal tract.
Typically IBS presents with abdominal pain or discomfort that is relieved by defecating
or it is associated with a change in stool frequency (increase or decrease) or a change in
the appearance of the stool (either too hard or too soft). IBS can also be divided into
those who tend to have diarrhea or constipation (Talley, 2007). Additionally IBS can be
comorbid with various other conditions such as gastro-esophageal reflux, fibromyalgia,
headache, backache, and psychological symptoms (Talley, 2007). Currently IBS is
7

characterized by recurrent episodes of abdominal pain, bowel discomfort, abdominal
bloating in the absence of any physiological abnormality, and changes in the frequency or
consistency of the stool in the absence of an organic etiology (Yale et aL, 2008).
Diagnostic criteria for IBS began in 1978 with the Manning Criteria which looked for a
visible abdominal distention, pain relieved with a bowel action, more frequent stools with
onset of pain, looser stools with the onset of pain, rectal passage of mucus, and a sense of
incomplete evacuation. The Rome I and Rome II criteria were brought about due to a
better understanding of the disease’s symptomatology. With the introduction of the
Rome criteria, some patients who may have met the Manning Criteria may not have met
either the Rome I or Rome II diagnostic criteria (Yale et al., 2008). In a study comparing
the different criteria, Yale et al., (2008) found that only a small percentage (45%) of IBScoded diagnoses actually met the criteria for Irritable Bowel Syndrome potentially due to
the more restrictive Rome criteria.
Hungin et al. (2005), in a two-phase community survey study, found the total
prevalence of irritable bowel syndrome to be 14.1% with 3.3% of those being
undiagnosed but meeting criteria. Abdominal pain/discomfort was the most common
symptom and most sufferers alternated between diarrhea and constipation. Additionally
Hungin et al. found that IBS sufferers missed more than twice as many workdays and had
more days in bed than nonsufferers (Hungin et al., 2005). The total cost of IBS, taking
into account not only the direct costs (i.e., doctor visits, outpatient/inpatient care,
emergency care, and diagnostic tests) but also indirect costs (i.e., absenteeism) can be
tremendous. Reports of direct cost expenditures associated with IBS have reached as
high as $20 billion (AGA, 2001). Given these are direct costs, indirect costs could be
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expected to total much more. In fact, the estimated total cost of IBS is comparable to that
of hypertension and congestive heart failure, both of which are long-term, persistent
conditions (Cash, Sullivan, and Barghout, 2005).
The etiology of IBS may involve multiple factors including: altered intestinal
motility, psychosocial factors and increased sensory function. Additionally, there are risk
factors such as genetic factors, food allergies, as well as abnormal brain-gut responses
(McFarland, 2008; Grundfast & Komar, 2001).

Multiple Chemical Sensitivity
Multiple Chemical Sensitivity (MCS) syndrome is a disorder typically
characterized as a condition where an individual’s belief that multiple disabling
symptoms are caused by very low-level exposure to environmental chemicals (Magill &
Suruda, 1998). MCS has a vague history. Smith (1992) suggests that Charles Darwin
possibly had what then was considered multiple allergies but today may be referred to as
multiple chemical sensitivity. A more widely recognized early proponent of multiple
chemical sensitivity is Randolph who in the 1950’s conceptualized MCS as a disorder
and went on to co-found the Society for Clinical Ecology (Terr, 1987).
MCS has been given various labels including: environmental illness, chemical
hypersensitivity syndrome, universal reactor syndrome, 20th century disease, chemical
AIDS, and ecologic illness but the term multiple chemical sensitivity appears to be most
commonly used in scientific literature (Johnson, 2008). Furthermore, Johnson (2008)
notes that MCS is the most controversial and the least recognized by the medical
profession at large of the various medically unexplained illnesses. Indeed, the American
Academy of Allergy and Immunology, the American Medical Association, the California
9

Medical Association, and the American College of Physicians among others have
rejected MCS as an established organic disease (Magill & Suruda, 1998).
In a comprehensive examination of MCS data Graveling et al (1999) adopted a
broad definition of MCS that included all literature describing relevant symptoms in more
than one organ system elicited by various unrelated chemicals at very low levels of
exposure. They found a general dearth of epidemiological evidence, a lack of
quantitative exposure data, and questionable qualitative data to support the existence of
MCS. Additionally they found an association existed between MCS and psychological
characteristics. Conversely, Caress and Steinemann (2003), in a two-phase study of the
prevalence, symptomatology, and etiology of MCS found evidence supporting a
physiological etiology for MCS as opposed to a primarily psychological one.
The prevalence rates for MCS vary. In 1981, the National Academy of Sciences
reported that up to 15% of the United States public might experience a heightened
sensitivity to common chemical products (Caress & Steinemann, 2003). In a study of
their own, Caress and Steinemann (2004) found that MCS affected 12.6% of the
populations and 3.1% of these were diagnosed medically. In 1995, the California
Department of Health Services conducted research into the epidemiology of MCS
(Kreutzer et al., 1999). Kreutzer et al. (1999) found that out of 4046 randomly selected
adults in California, 15.9% of the respondents reported unusual sensitivity to common
chemicals and 6.3% of respondents reported being diagnosed with an environmental
illness or MCS by a physician.
Diagnostic criteria for MCS varied based on the definition prior to 1987 when
Cullen outlined seven major diagnostic features of MCS (Graveling et al, 1999). Cullen
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(1987) proposed the following definition for MCS that has become extensively applied in
the published literature:
1. The disorder is acquired in relation to some documentable environmental
exposure, insult, or illness.
2. Symptoms involve more than one organ system.
3. Symptoms recur and abate in response to predictable stimuli.
4. Symptoms are elicited by exposures to chemicals of diverse structural classes and

toxicological modes of action.
5. Symptoms are elicited by exposures that are demonstrable even at a very low
level.
6. Exposures that elicit symptoms must be very low, by which we mean many
standard deviations below average exposures known to cause adverse human
responses.
7. No single widely available test of organ system function can explain the

symptoms.
Common symptoms of MCS include fatigue, difficulty concentrating, depressed mood,
memory loss, weakness, dizziness, headaches, heat intolerance, and arthralgias. Also, the
typical patient with MCS has a firm belief that the symptoms are the result of a chemical
exposure. Additionally, those patients with MCS tend to significantly alter their behavior
in an attempt to avoid those chemicals they feel might be causing their symptoms (Magill
& Suruda, 1998). As with other medically unexplained illnesses, gender is a good
predictor of MCS with women making up 60-80% of samples in clinical studies
(Johnson, 2008).
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Although the exact etiology of MCS is unknown, there are various proposed
mechanisms that attempt to explain MCS. These can generally be grouped into four
categories: physical, stress, misdiagnosis, and illness belief (Magill & Suruda 1998) or,
more broadly, into physiological vs. psychological etiologies (Reid, 1999). In their
landmark paper on MCS, Graveling et al (1999) found physiological theories to
encompass immunological deficits, respiratory disorders or neurogenic inflammation,
kindling and sensitization models of the olfactory-limbic system, the Toxicant induced
loss of tolerance or TILT model, and porphyria. Psychological theories include
conditioned responses (e.g., classic Pavlovian conditioning) and psychiatric disorders.

Gulf War Illness
In 1990-1991, shortly after the Persian Gulf War, a number of veterans began
complaining about a wide range of symptoms, the most common of which were; fatigue,
headache, sleep disturbance, low mood, and memory loss (Ismail & Lewis, 2006). Many
of those veterans felt their symptoms were a direct result of what they had been exposed
to during their tours of duty. This is not an uncommon occurrence when discussing
veteran’s responses to war. Indeed, Hyams et al, (1996) details a long history of medical
illnesses unexplainable by medical personnel dating back to the US Civil War.
Following the Civil War soldiers complaining of shortness of breath, palpitations, and
sharp or burning chest pain following exercise were said to have an irritable heart.
Additionally some Civil War soldiers complaining of obsessive thoughts of home
accompanied by apathy, diarrhea, loss of appetite, and occasionally fever were said to
have nostalgia.
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Hyams et al, (1996) also noted that in World War I, soldiers reported shortness of
breath, palpitations, and chest pain along with fatigue, headache, confusion,
concentration problems and forgetfulness were thought to have soldier’s heart or effort
syndrome. Acute combat stress reaction, which manifested in an exaggerated startle
response, severe anxiety, and a dazed or detached manner, was also identified.
World War II saw the continuing appearance of both acute combat stress reaction
and effort syndrome. Studies during W.W.II found a somatic presentation for acute
combat stress reaction, which included fatigue, palpitations, diarrhea, headaches,
impaired concentration, forgetfulness, and disturbed sleep. Similar presentations were
noted during the war in Korea as well as Vietnam (Hyams et al., 1996).
DeFraites et al., (1992) first coined the term “Gulf War Illness” in response to an
outbreak of an alleged mystery illness by approximately 79 Gulf Veterans in the United
States. Following the Persian Gulf War, veterans began complaining of symptoms
including fatigue, shortness ofbreath, joint pain, headaches, skin rashes, GI complaints,
forgetfulness, poor attention, and sleep disruptions (Axelrod & Milner, 2000). US
veterans did not only report these symptoms, but similar complaints were reported in the
UK, Canada, Australia, and Denmark (Iversen, Chalder, and Wessely, 2007). The
similarity of the various symptoms (i.e., medical, cognitive, affective) prompted
recommendations for government-sponsored research (Axelrod & Milner, 2000). Ismail
and Lewis (2006), in a review of relevant research studies on Gulf War Illness, found
minimal differences between Gulf veterans and non-Gulf veterans with the exception of a
CFS-like illness. Gulf veterans were at least 2-3 times more likely to report symptoms
associated with CFS as compared to non-Gulf veterans. At the time they noted that the
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possibility existed that Gulf War Illness was caused by some unknown agent that will
eventually be discovered and while there was no convincing evidence at the time for a
new Gulf War Syndrome, Ismail and Lewis (2006) felt there did not exist a satisfactory
explanation for the increased multi-symptom conditions in Gulf War Veterans. Recent
findings from the Research Advisory Committee on Gulf War Veterans’ Illnesses (2008)
argue for the existence of a cohesive diagnosis for Gulf War Illness. Studies find that
between 25 and 32% of veterans who served in the first Gulf War are affected by one
symptoms or another above that noted by non-deployed military personnel. Furthermore
the Advisory Committee found that while Gulf War Illness is characterized by symptoms
not generally explained by established medical diagnoses, these symptoms typically
include a combination of memory and concentration problems, persistent headache,
unexplained fatigue, and widespread pain, and can also include chronic digestive
difficulties, respiratory symptoms, and skin rashes.

Somatoform Disorder
Whether the diagnosis is Gulf War Syndrome, fibromyalgia or IBS, multiple
chemical sensitivity or chronic fatigue syndrome, it is possible they are simply somatic
manifestations of a psychiatric disorder. These different functional somatic symptoms
are clearly a major health issue, yet the question remains whether they are the result
physiological or psychological factors. One thing is known; these disorders are
persistent, disabling and costly. Indeed, while patients with medically unexplained
symptoms can account for up to 30% of all primary care consultations, physicians will
often assume that symptoms are due to psychological factors (Kirmayer et al, 2004).
Nimnuan, Hotopf and Wessely (2001) found that being female, younger, and currently
14

employed was associated with medically unexplained symptoms and while psychiatric
morbidity was not associated with the presence of MUI, it was more likely in individuals
complaining of multiple symptoms.
The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American
Psychiatric Association, 1994) identifies several symptoms, which fall under the category
of somatoform disorders. This category includes a wide range of complaints typically
characterized by the symptoms of a somatic illness that cannot be fully explained by a
known medical condition or the direct effect of a substance. The symptoms also must
cause clinically significant distress in social, occupational, or other areas. Additionally if
there is a related general medical condition, the psychical complaints or impairments are
excessive in relation to what might be expected.
Recent attempts to explain MUI via psychological concepts have based
themselves on the concepts of dissociation, conversion, and somatization (Brown, 2004).
In medically unexplained symptoms, the most commonly reported comorbid psychiatric
disorders include depression, anxiety, and somatization disorder. Moreover there is no
clear delineation between psychological symptoms and those psychiatric symptoms in
medically unexplained symptoms. These symptoms include, but are not limited to,
fatigue, cognitive difficulties, sensitivity to pain and sleep problems (Johnson, 2008).
Richard Brown, in a 2007 article focused on medically unexplained symptoms, remarked
on how difficult it is to distinguish between MUI and physical symptoms that may be part
of a larger psychiatric condition such as depression or panic disorder. Furthermore
physical symptoms can be misdiagnosed as medically unexplained despite being present
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only during episodes of panic or depression which may not be severe enough to meet
formal criteria for panic or depression (Brown, 2007).
In 2003 Henningsen et al, performed a meta-analytic review looking at medically
unexplained physical symptoms and their association to anxiety and depression. They
found a moderate effect size for the association between MUI and depression and
anxiety. Additionally they found a relationship between the functional somatic
syndromes and depression (Henningsen et al, 2003). Sykes (2006) also notes that often
times patients with medically unexplained symptoms will also have concomitant mental
disorders such as anxiety and depression although these disorders are often not diagnosed
or treated. This has been confirmed in other research. In a research project with over
50,000 participants, looking at the association between anxiety, depression, and somatic
symptoms, Haug et al. found a significant relationship between anxiety, depression, and
functional somatic symptoms regardless of age and gender (Haug, Mykletun, & Dahl,
2004). Perhaps then it is possible that medically unexplained symptoms may have more
to do with psychological rather than physiological issues. In fact, it has been suggested
that medically unexplained symptoms such as chronic fatigue syndrome may result from
the suggestibility in somaticizing patients (Fink, 1996).
In an effort to summarize some of the different psychological processes that may
contribute to somatic distress in patients, Kirmayer et al. (1994) noted that neuroticism,
physiological reactivity, symptom perception, somatic attention, coping resources,
symptom threshold, and the individual’s tendency to seek help all played a role. While
many patients with Somatoform Disorder might meet criteria for other psychiatric
disorders, Somatoform Disorder may represent the extreme end of a somatization

16

continuum (Johnson, 2008). In an effort to address that very continuum, Escobar et al.
(1987) proposed the concept of an abridged somatization which accounted for individuals
who might not meet the full diagnostic criteria for Somatoform Disorder but still had
somaticizing qualities in their presentation. To meet the criteria for abridged
somatization, men must have at least four unexplained physical syndromes and women
complaining of at least six unexplained physical syndromes would also meet criteria.
When looked at in this light, those individuals with abridged somatization now were
associated with elevated levels of disability, psychopathology, and, subsequently,
medical services (J. I. Escobar, et al., 1987). Indeed, Escobar also found moderate levels
of somatization to be widespread in primary care with abridged somatization estimated to
be at 22% of the population (J. Escobar, Waitzkin, Silver, Gara, & Holman, 1998). If
indeed these different medically unexplained symptoms have, potentially, both medical
and psychiatric underpinnings, are there other similarities between the different Mill’s?
Is it possible that the different medically unexplained syndromes are really just different
sides of the same coin?
In a study looking at whether functional somatic syndromes are discrete or
similar, Wessely, Nimnuan, and Sharpe (1999) found a substantial overlap exists between
individual syndromes and that these similarities outweigh the differences. They also note
the differences between the different functional somatic syndromes are based primarily
on which medical specialist sees the patient, meaning that a rheumatologist would be
inclined to diagnose a patient with fibromyalgia, whereas a gastroenterologist would be
more likely to diagnose that very same patient with irritable bowel syndrome. In a
longitudinal study of patients with functional somatic symptoms, Hartman et al., (2004)
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also found little evidence that the different symptoms cluster into distinct, well defined,
syndromes, and instead suggested that patients with functional somatic symptoms not be
classified into medical subspecialty syndromes (i.e., IBS). While there is mounting
evidence that similarities between different MUI syndromes point to a common
underlying disturbance, and that overlap is substantial (e.g., Wessely, Nimnuan, and
Sharpe, 1999), it is not complete (Aaron & Buchwald, 2001). It is the purpose of this
study to help elucidate that relationship and, if possible, clarify the position of discrete vs.
overlapping conditions.

18

Statement of the Problem

Currently the question of whether medically unexplained symptoms are distinct
entities or part of an overarching psychological condition (i.e., somatoform disorder)
remains unanswered. Previous studies have attempted to demonstrate single vs. multiple
factor solutions to medically unexplained symptoms (Nimnuan et al., 2001; Wessely,
Nimuan, and Sharpe, 1999). Indeed, Hartman, et al. (2004), in an attempt to identify
distinctive features in patients with functional somatic complaints found the diversity of
somatic complaints did not support the existence of distinct syndromes. Due to the
nebulous nature of medically unexplained illnesses along with the generally inconclusive
research results, this study will endeavor to ascertain whether medically unexplained
illnesses should be considered a homogenous concept or whether they are indeed discrete
entities. This study will present three structural equation models in an effort to determine
whether FMS, IBS, CFS, MCS, and psychosomatic complaints in Gulf War veterans are
discreet syndromes or, in fact, all part of a larger concept called Gulf War Syndrome.

Hypotheses
Hypothesized Model 1. The medically unexplained symptoms of MCS, IBS,
CFS, FMS, and psychosomatic complaints are all part of a more expansive Gulf War
Illness. The different goodness of fit indices will be within acceptable limits (RMSEA
<.06, CFI >.95). Please refer to Figure 1. This model will be referred to as the single
factor model.
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Figure 1. First-Order CFA Model of Expected Paths between Variables and Factor
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Hypothesized Model 2. The medically unexplained symptoms of MCS, IBS,
CFS, FMS, and psychosomatic complaints are individual discreet factors that do not
significantly overlap. The different goodness of fit indices will be within acceptable
limits (RMSEA <.06, CFI >.95). Please refer to Figure 2 for expected paths between
variables and factors. This model will be referred to as the five-factor model.
Hypothesized Model 3. While MCS, IBS, CFS, FMS, and psychosomatic
complaints are individual first-order factors, the overlap, based on past research, indicates
the existence of a possible second-order factor; Gulf War Illness. The resulting goodness
of fit indices will be within acceptable limits (RMSEA <.06, CFI >.95). Please refer to
Figure 3. This model will be referred to as the hierarchical factor structure model.
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Hypothesis 3: Biopsychosocial Solution
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Methods

Introduction to Structural Equation Modeling
Structural equation modeling (SEM) is frequently used as a method to determine
relationships among and between variables as well as among variables that may predict a
direction of causality. While SEM is not used to imply causality, it may be used to
interpret the sequencing of constructs and their relative relationships among other
constructs. Byrne (1994) identifies two validation methods employed by CFA. The first
involves the validation of a theoretical construct (p. 41) while the second can be
completed to test the validity of a highly reliable measure (p. 73). The key concept in
both uses of CFA is that the scale used for validating theory and measure is a highly
reliable and widely used scale consequently inferring that it must always be based on
theory and research. Byrne (2006) additionally notes that a CFA is appropriately used
when there is some previous theoretical knowledge of the underlying latent variable and
it’s structure. Furthermore, using this knowledge of theory or previous empirical
research, the researcher is able to postulate relationships between the observed measures
and the underlying factors a priori.
Visually, CFAs are uncomplicated and inspection can help in understanding the
theory. A beneficial aspect of CFA allows for multivariate analysis wherein factors can
be confirmed to make higher order or secondary factors and are allowed to correlate
based on theory. CFA is also useful when validating latent constructs by including
indirect associations with observable data (Byrne, 1994, p. 6). The most useful aspect of
CFA is testing the fit of the model to the observed data, therefore validating the theory
and testing against the population (Byrne, 1994, p. 6). Testing the data against a
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population uses maximum likelihood estimation where CFA gives estimates in the model
that were maximized to the point at which it is the most likely to be observed in the
population again if data were obtained from the same population (Raykov &
Marcoulides, 2006, p. 30). Using CFA in EQS also helps to improve the hypothesized
model by giving suggestions about relationships to be added or deleted based on what
will be most parsimonious with the population. However, it should be noted that theory
should lead the addition of loadings and not the computer software.
As with any other statistical procedure, CFA employs basic assumptions pertinent
to the method. Data used should be normal, linear, homogenous, void of outliers, and
without significant multicollinearity. Multicollinearity > 0.85 should be corrected on the
grounds that mathematical procedures employed in the CFA process will not run (Kline,
2005, pp. 56-57). The items used to assess the construct must be continuous as well. All
measurement error found in the model must be independent of each other and the factors.
Confirmatory factor analysis works toward estimating parameters. In CFA
parameter estimates are used to convey the relationship among indicators (items) and
factors, and latent factors to higher order factors. Byrne (1994, p. 16) refers to parameter
estimates as regression paths indicating the relationship of CFA as part of structural
equation modeling with the use of multiple regressions. However, CFA is distinct from
SEM in that SEM path loadings are unique variance (beta weights), but CFA path
loadings are based on shared variance to the factor. Similar to regression coefficients, the
range of values for parameter estimates is between -1 and 1, meaning a perfect
relationship. Parameter estimates essentially test the strength of the relationship between
factors and indicators by standardizing the estimate with the division of the standard
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error. This conversion makes it possible to compare the z score obtained from the
computation to the null hypothesis, depending on alpha level and sample size (Byrne,
1994, p. 60).
SEM also assesses factor loadings. Factor loadings indicate the degree to which
an item (shown as a manifest variable) loads on a particular construct (or latent variable)
(Ullman, 2001; Byrne, 1995). Higher factor loadings indicate that the item was well
indicated by the construct, while lower factor loadings indicate that the item was poorly
indicated by the construct. When using standardized factor loadings, a perfect factor
loading is 1.0, while a completely unrelated factor loading is 0. When estimating factor
loadings, it is important to manually set or “constrain” one of the factor loadings to 1.0
before running an analysis (Byrne, 1995). Typically the item with the most reliable
factor loading is set to 1.0 because this item will invariably load highest on the factor.
The purpose of setting one of the paths to 1.0 is to create an interpretable metric for the
paths to be estimated on. Additionally, SEM can estimate the statistical significance of a
factor loading based on either at or z distribution (depending on sample size).
The use of structural equation modeling methods like CFA requires certain steps
to be taken to ensure the stability of the model. Overidentified models, or models in
which more parameter estimates are present than data points, are required to acquire the
best fitting model. In order to establish an overidentified model, certain parameter
estimates must be fixed to 1.0, where estimation of the variance will be obtained when a
path is fixed, or the path will be estimated when the variance is fixed (Byrne, 1994, p.
16). Failure to do so may result in an underidentified model (i.e., more parameters than
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data points). A just identified model is one in which all parameters are being estimated
making it difficult to test the model.

Subjects
In 1995, 2011 veterans were randomly selected from the Gulf War Veterans
Health Registry and sent a questionnaire asking about possible physical and
psychological symptoms they were currently experiencing. These veterans lived in one
of seven states: New Jersey, New York, Pennsylvania, Delaware, Ohio, Illinois, and
North Carolina and were chosen for their proximity to the Veteran’s Administration
Hospital of East Orange, NJ. Additionally, all were noted to be concerned about their
health thereby contacting the Health Registry. Consequently, the sample used in this
study is not a random sampling of Veterans who served in the Gulf War; rather it is a
case-rich sample that includes many subjects who present with the symptoms examined
in this study. Of the 2011 questionnaires mailed, 4% were returned as undeliverable
dropping the number of potential participants to 1935. Of those 1935 potential
participants, 60% of the questionnaires were completed and returned by the respondents
dropping the total number of participants to 1161 (Kipen et. al., 1999).

Analytic Strategy
The Gulf War Veterans Health Questionnaire (GWVHQ) was produced by the
Gulf War Research Center. The respondents were asked to examine a list of 48 symptom
complaints. The 48-item symptom checklist was modeled after a review of systems,
which is a commonly used procedure in internal medicine to assess physical symptoms in
patients (Kipen, et al., 1999). The questions covered symptoms from all areas of the
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body (e.g., head, internal organs, extremities). Additionally the questionnaire asked
respondents about symptoms typically found in chronic fatigue patients. It was designed
to discover potential causes for the different medically unexplained problems military
personnel who had served in the Persian Gulf during operations Desert Shield and Desert
Storm were experiencing. In all, the questionnaire asked questions relating to
respondents’ medical history, tobacco, alcohol and drug use, wounds/medical treatment
received during war, and symptom reporting. Respondents were also asked about
stressors both pre-war/deployment and during the war and whether they had ever been
told by a doctor that they had a health condition and if so, what it was. In an unpublished
in-depth study looking at war-related stressors and physical as well as psychological
complaints reported by Gulf-War veterans, Hallman (1998) found that while the vast
majority (95%) of respondents reported being in good to excellent health pre-deployment,
there was only a small correlation found with their current (post-deployment) health
(r=.15, p<.001). In the questionnaire respondents indicated whether they had experienced
“persistent or recurring” problems within the last year, and if so, whether the problems
were “mild”, “moderate”, or “severe”. Additionally Hallman found that respondents
endorsed an average of 9.9 mild symptoms, 9.5 moderate symptoms, and 6.1 severe
symptoms averaging out to a total of 25.5 symptoms. The average number of items
endorsed by those reported to be in very good health was 14 symptoms, 21 symptoms for
those in good heath, 31 for those who reported being in fair health, and 38 out of a
possible 48 symptoms for those reported to be in poor health. Respondents endorsed
items consistent with depression (20.5%), PTSD (19.0%), Arthritis (16.3%), High Blood
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Pressure (15.2%, and Chronic Fatigue Syndrome (14.4%) at a significantly higher rate
than pre-deployment.
For this study, items from the GWVHQ were broken down theoretically into one
of five areas which encompass MUI: musculoskeletal complaints, perceptions/sensation
complaints, gastro-intestinal (GI) complaints, general malaise, and a miscellaneous
category consisting primarily of sores, rashes, and body complaints. Items with
significant overlap between theoretical factors were not incorporated into the study.
These items include questions relating to headaches or vision, muscle aches/cramps,
painful urination, numbness and pain in extremities as well as sensitivities to cold or heat.
These were then placed into one of five medically unexplained illness categories: CFS,
IBS, FMS, MCS, and psychosomatic complaints.
Model Testing and Specification. The use of CFA to test a theory by way of
construct validation uses the maximum likelihood estimation method. As mentioned
previously, the benefit of maximum likelihood estimation (ML) is to maximize the factor
loadings to a degree in which another sample from the population would yield similar
factor loadings (Kline, 2005, p. 112). Inherent to ML is the process by which the actual
factor loadings are derived. To maximize the relationship between the data and the
population, iterations must be made in which the data and population are consistently
trying to match. Applying the ML method means that the observed data model will be
tested against the said population. To test the degree of fit between the observed model
and the population model a Chi-square statistic must be used. A model that matches the
population is a “good” fitting model and one in which the Chi-square statistic is not
significant.
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To test the fit of the hypothesized model to the population model different fit
indices can be used to convey such information. In this study the comparative fit index
(CFI) will be used to report the fit of the model because it is the most commonly used.
The CFI compares the hypothesized model with the independence model, which is
essentially the null model wherein no relationships are present in the model. The higher
the CFI the more likely it is that the hypothesized model is better fitting to the data and
population than the independence model. Values of CFI range up to 1.0 and any value
approximately close to .95 is considered to be a “good” fitting model (Hu & Bender,
1999). Another important fit index to report is the root mean square residual (RMSEA).
Unlike the CFI, RMSEA is based on the covariance of the residuals left over by the
observed data when compared to the population. Ideally, the smaller the RMSEA the
better fit because less error is being left over. Hue and Bender (1999) suggests “good”
standardized RMSEA to be below .06 in order to reduce type II errors. When reporting
RMSEA the confidence interval should be included to better understand how the residual
error in the model may be exhibiting.
When running any statistical analysis it is important to include the power with
which one has to report the findings. Using McCallum, Browne, and Sugawara’s (1996)
criteria for power estimates and degrees of freedom, it was established that with a
maximum of 44 degrees of freedom, the 430 participants were sufficient to achieve
adequate power.
As previously noted, the normality of the sample data being used has been
violated and an extension of Maximum Likelihood (ML), Robust values, will be used to
analyze the fit of the model. Specifically, the Satorra-Bentler scaled Chi-square statistic
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will be used because it has been shown to be the most reliable of the robust statistics and
accounts for the non normal data as well as the estimation method.

Preliminary Data Analyses
Descriptive Statistics. The mean age of respondents at the time of the survey
was 35 years old while the mean age for non-respondents was 33. Ninety-one percent of
those who returned the questionnaires were male, 70% described themselves as
Caucasian, 20% as African American, 4% as Hispanic, 2% as Native American, and 3%
as “other”. Sixty-nine percent of the respondents served in the Army, 14% in the
Marines, 8% in the Air Force, 6% in the Navy, and 1% in the Coast Guard. The majority
(52%) of respondents served in active-duty units while 23% and 18% served in reserve
and guard units respectively. Furthermore, 47% of the sample stated they had served in
the Gulf as enlisted personnel, 40% as noncommissioned officers, and 10% as officers.
One percent of respondents did not respond to their rank. Just over half of respondents
reported being married at the time of deployment (51.5%), 6.8% were divorced, 3%
separated, 0.3% widowed, 34.8% were single, never married, 2.7% living with a
significant other, and 1% did not respond to the question. See Table 1.
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Table 1
Descriptive demographic data for GWVHQ respondents
(N = 1161)
Variable
Race
American Indian or Alaskan native
Asian or Pacifica islander
African American (not of Hispanic origin)
Hispanic
Caucasian (Not of Hispanic origin)
Other
Missing
Rank
Enlisted
NCO
Officer
Other
Missing
Marital Status
Married
Divorced
Separated
Widowed
Single, never married
Not married, living with mate
Missing
Gender
Male
Female
Missing_________________

N

%

23
5
234
47

2.0
.4
20.2
4.0
70.4
2.7
.3

817
31
4
542
470
118
14

17

46.7
40.5
10.2
1.2
1.5

597

51.4

74
32
3
416

6.4

35.8

28

2.4

11

.9

1058
100
3

91.1
8.6

2.8
.3

Variable
Branch of Service
Army
Marines
Navy
Air Force
Coast Guard
Missing
Duty Type
Active Duty
Reserve Duty
Guard Duty
Unknown
Missing
Health Status at Deployment
Excellent
Very good
Good
Fair
Poor
Missing

N

%

805
161

69.3
13.9
6.3

73

94
12
16

8.1

1.0
1.4

596

51.3

270

23.3
18.5

214
77
4

6.6

497

42.8

453
153

39.0
13.2

39
12

3.4

7

.3

1.0
.6

.3

Exploratory Data Analysis. In the case of this study, the data set of 1161
participants from the GWVHQ will be randomly divided into two sections using SPSS,
the Statistical Package for the Social Sciences. The first half will be used for exploratory
statistical analysis and the second half to be used for the confirmatory factor analysis.
In an effort to determine the number of factors that will be used in the CFA as
well as the items that load on the particular factors, exploratory factor analyses were
conducted on the first half of the data set, using principle axis extraction and promax
rotation. Various factor numbers were explored, however a decision was made to extract
five factors based on the theory of this study. Table 2 shows the items and factor
loadings from the final exploratory factor analysis. The items broadly load on factors
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that match the theory described in this study, in that the CFS symptoms generally loaded
highest on a factor, MCS symptoms loaded highest on another factor, and so on. These
results also were followed in constructing the parcels used in the later confirmatory factor
analyses, described below.

Table 2.
Structure matrix of exploratory factor analysis
Factor
GWYHQ Items
1.
How sad in past month or two
2.
How blue in past month or two
3.
How uneasy in past month or two
4.
How gloomy in past month or two
5.
How worried in the past month or two
6.
How tense in the past month or two
7.
How nervous in the past month or two
8.
Difficulty swallowing
9.
Throat problems
10. Swollen glands
11. Coughing
12. Difficulty Breathing
13. Ability to taste
14. Mouth, teeth, or gums
15. Unexplained weakness
16. Fatigue (not due to exercise)
17. Prolonged fatigue or illness after mild exercise
18. Unrefreshing sleep (waking up tired)
19. Feeling anxious or upset
20. Sudden mood changes
21. Feeling sickly
22. Difficulty concentrating
23. Difficulty remembering things
24. Sleeping more than usual
25. Abdominal pain
26. Stomach or digestive system
27. Nausea
28. Diarrhea
29. Abdominal gas
30. Vomiting
31. Constipation
32. Walking down the detergent aisle
33. Going into a beauty parlor or barber shop
34. Walking into a room with brand new carpets
35. Reading a freshly printed newspaper
36. Cologne, aftershave or perfume
37. Sitting in a room where someone is smoking

1

2
.474

.892
.887
.869
.869
.844
.816
.789
.339
.306

.480
.405
.459
.364
.376
.394
.746
.745

.327

.724

.375
.414
.380
.406
.557
.524
.547
.563
.713
.690
.579
.609
.543

.641
.621
.600
.549
.564
.454
.538
.450
.531
.502
.622
.485

.387
.333

.397
.306
.345
.300

.357
.374

3

.560
.569
.557
.557
.510
.546
.506
.420

.397
.405
.500
.530
.427

.479
.834
.832
.819
.784

4
.330
.342

.401
.347

.408
.429
.411
.489
.419
.463
.492
.475
.376
.378
.596
.541
.593
.506
.460

.304

.333
.332

.387
.395
.419
.388
.386
.407

.763
.760

.696

.412
.364
.446

.477

.420

.440

.724

.457

.382

.349
.501
.466
.509
.415
.458
.507
.416
.348
.361

.582
.555
.539
.548
.446
.503
.409
.356

.377

.772
.772

.472

.816
.807
.765
.689
.683
.671
.543

.314
.336

Extraction Method: Principal Axis Factoring.
Rotation Method: Promax with Kaiser Normalization.
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.391

.354
.339
.417
.302
.333

.332

.792
.760

.328
.305

.722
.703
.702
.477

.343

.364

.302

.310

5
.392
.392
.397
.385
.357
.381
.369
.379
.331

The five factors broke down theoretically into the different medically unexplained
illnesses including; Psychosomatic (items 1-7), Chronic Fatigue Syndrome (items 8-14),
Fibromyalgia (items 15-24), Irritable Bowel Syndrome (items 16-31), and Multiple
Chemical Sensitivity (items 32-37). As might be expected when dealing with questions
related to medically unexplained illnesses (see Wessely, Nimnuan, and Sharpe, 1999),
there was some overlap between factors as shown in Table 3 although no correlation was
excessively high.

Table 3.
Factor correlation matrix
Factor
l
2
3

5
6

1

2

3

4

5

1.000
All

All

.626
.592
1.000
.612
.465

.423

.426
.464
.465

.626
.423

.426

1.000
.592
.579
.464

.579
.612
1.000

.404

.404

1.000

Confirmatory Data Procedure. Assumptions of normality were checked for the
confirmatory sample along with missing data. Additionally participants in the
confirmatory sample with missing data were checked using Little’s MCAR test to
determine if the subject data was missing completely at random. MCAR exists when
missing values are randomly distributed across all observations. Little’s MCAR test is a
chi-square test for helping determine whether data is missing completely at random. In
this case Little’s MCAR test was not significant (Chi-Square = 4857.358, DF = 4807,
Sig. = .302) meaning the missing data was completely random and consequently those
cases can be deleted. Also deleted were cases with extreme outliers or questions that
were highly kurtotic. These cases included: ability to taste, difficulty swallowing,
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vomiting, and constipation. The exceptions to this were the items dealing with Multiple
Chemical Sensitivity. Although kurtotic, removing those outliers would have
dramatically reduced variability. In defense of leaving these items in, investigators have
documented that Gulf War veterans reported roughly twice as many symptoms as those
who were not deployed including higher rates of fibromyalgia, depression, anxiety,
respiratory symptoms, and chronic fatigue (Iowa Persian Gulf Study Group, 1997).
Kipen et al. (1999) in a study examining the prevalence of chronic fatigue and chemical
sensitivities in Gulf Registry veterans found that upward of 13% of respondents met
criteria for Multiple Chemical Sensitivities. Due in part to these findings, the decision
was made to retain the items for the Multiple Chemical Sensitivity factor.
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Table 4.
GWVHQ item means, standard deviations, skewness, and kurtosis for the
confirmatory sample (N = 430)
GWVHQ Items

Mean

SD

Skewness

1.

Mouth, teeth, or gums

.75

.988

.972

.393

2.

Throat problems

.55

.843

1.345

.684
.949

Kurtosis

3.

Swollen glands

.51

.849

1.466

4.

Coughing

.85

.751

.675

5.

Nausea

.51

.972
.821

1.497

1.264

6.

Stomach or digestive system

.97

1.072

.622

-1.006

7.

Diarrhea

.79

.980

.928

.376

8.

Abdominal gas

1.00

1.047

.579

.972

9.

Abdominal pain

.76

.976

1.044

100

10.
11.

Difficulty concentrating

1.14

.361

Difficulty remembering things

1.33

1.057
1.076

-1.171
-1.256

12.

Feeling sickly

.87

.990

.770

-.633

13.

Unrefreshing sleep

1.59

1.095

131

-1.287

.159

14.

Sleeping more than usual

.90

1.084

.780

.827

15.

Fatigue (not due to exercise)

1.46

1.083

.063

-1.270

16.

Prolonged fatigue or illness after mild exercise
Unexplained weakness

1.03
1.01

1.137

17.

1.077

.609
.611

-1.124
.990

18.

Feeling anxious or upset

1.18

1.109

.388

-1.227

19.

Sudden mood changes

1.32

1.150

.232

-1.387

20.

Cologne, aftershave or perfume

1.54

.942

1.826

2.682

21.

Walking down the detergent aisle

1.50

.860

1.895

3.462

22.

1.50
1.54

.943
1.041

2.079
2.149

3.893

23.

Going into a beauty parlor or barber shop
Walking into a room with brand new carpets

24.

Reading a freshly printed newspaper

1.40

.967

2.749

25.
26.

Sitting in a room where someone is smoking
How nervous in the past month or two

1.97

.983
1.190

.765
.467

.440

2.47

27.

How tense in the past month or two

2.77

.262

.792

28.
29.

How worried in the past month or two
How uneasy in past month or two

2.76
2.53

1.166
1.144
1.174

.268

.698
-.687

.442

3.879
6.895
.709

30.

How sad in past month or two

2.31

1.210

.698

31.

How blue in past month or two

2.28

1.234

.680

.479
.598

32.

How gloomy in past month or two

2.24

1.206

.722

.504

Due to the large number of items in the study, items were parceled within their
theoretical factors. Matsunaga (2008) describes several benefits to parceling data both
from a psychometric and modeling perspective. The first psychometric advantage of
parceling includes enhanced scale communality and reduction of random error. As
Matsunaga explains, the practice of aggregating multiple items into parcels allows for a
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greater distillation of the underlying latent factor. Consequently it can be argued that
parceling allows for a better approximation of the distribution of the target construct as
well as an increase in a model’s efficiency in defining the latent construct. Furthermore,
Bandalos and Finney (2001) have found that parceling can mitigate the problem of non
normal data by somewhat normalizing the distribution. Indeed Bandalos (2002) found
that even data with severe nonnormality, meaning skewness of up to 5.0 and kurtosis of
25.0, became almost normal when parceled. Bandalos (2002) additionally found that
beyond just normalizing the data, parceling generally improved the model fit when
compared to the item-based approach regardless of the number of parcels per factor. This
then leads to the question of how many parcels should one have per factor. Matsunaga
(2008) recommends approximating three parcels per factor. This is in an attempt to
balance the need to keep the number of parcels at a minimum to improve the model fit
while being conscious of the fact that multiple parcels protect against estimation bias.
Beyond determining whether or not to parcel, and if so, how many parcels per factor,
there remains the question of how to parcel. There exist multiple methods of how to
form parcels including; random algorithm, factorial algorithm, correlational algorithm,
radial algorithm, and a content-based method (Little et al., 2002; Rogers & Schmitt,
2004; Matsunaga, 2008). In 2000, Landis, Beal, and Tesluk also proposed that parcels
could be created theoretically based on item content. This study performed a factor
analysis of each factor and, depending on the number of items in the factor tried to divide
the items evenly. The factors were extracted using Principle Axis Factoring and a
Promax Rotation with Kaiser Normalization. Composites were created by summing and
averaging the items in each factor and are presented in Tables 5-9.
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Table 5.
Chronic Fatigue Syndrome: Structure Matrix
Parcel

Factor

Items

Sore Throat
Coughing

Swollen Glands
Throat Problems
Coughing
Mouth, teeth, or gums

1

2

.786
.625

.394
.543

.402

.770
.444

.412

Principle Axis Factoring, Promax Rotation with Kaiser Normalization

Table 6.
Irritable Bowel Syndrome: Structure Matrix
Parcel

Factor
1
.796
.762
.628
.699
.551

Items

GI Distress
Nausea

Abdominal Pain
Abdominal Gas
Diarrhea
Stomach or digestive system
Nausea

2

.682
.622
.607
.814
.657

Principle Axis Factoring, Promax Rotation with Kaiser Normalization

Table 7.
Fibromyalgia: Structure Matrix
Parcel

Factor

Items

Fatigue

Concentration
Mood

Fatigue (not due to exercise)
Prolonged fatigue or illness after mild exercise
Unexplained weakness
Unrefreshing sleep (waking up tired)
Feeling sickly
Sleeping more than usual
Difficulty concentrating
Difficulty remembering things
Sudden mood changes
Feeling anxious or upset

1
.920
.864
.820
.767
.751
.632
.618
.645
.615
.620

2

3

.633
.594
.611
.614
.614

.572
.581
.608
.587
.554
.439
.661
.589
.883
.856

.404

.912
.860
.612
.643

Principle Axis Factoring, Promax Rotation with Kaiser Normalization
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Table 8.
Multiple Chemical Sensitivity: Structure Matrix
Parcel

Items

Floral Scents

Industrial Scents

Walking down the detergent aisle
Going into a beauty parlor or barber shop
Cologne, aftershave, or perfume
Walking into a room with a brand new carpet
Reading a freshly printed newspaper
Sitting in a room where someone is smoking

Factor
1
.828
.766
.715
.602
.614
.406

2
.639
.632
.496
.848
.813
.426

Principle Axis Factoring, Promax Rotation with Kaiser Normalization

Table 9.
Psychosomatic Complaints: Structure Matrix
Parcel

How tense in the past month or two

Factor
1
.885

2
.631

Items

Anxiety

Depressed

How uneasy in past months or two

.880

.732

How nervous in the past month or two

.844

.642

How blue in past month or two

.710

.976

How sad in past month or two

.723

.952

How gloomy in past month or two

.706

.929

Principle Axis Factoring, Promax Rotation with Kaiser Normalization
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Results

Results of Hypothesized Relationships
A Confirmatory Factor Analysis was run on all three models to determine which
model fit the data better. Only two of the models were successfully run. The Five Factor
Solution model was not able to run due to issues with linear dependency. This will be
explained in the following sections. As mentioned previously, due to the assumptions of
normality being violated in the data set, both ML and Robust statistics were included
(Table 10). Additionally, the fit indices for the three models are based on a single run of
the data. No post-hoc model-fitting was performed on the confirmatory sample.

Table 10.
Fit Indices for Models (N = 430)
Model

f

CFI

RMSEA 90% Cl

44

475 9***

.802

.151 (.14, .16)

Single Factor Solution
Maximum Likelihood Statistics

44

622.2***

.772

.175 (.16, .19)

Five Factor Solution
Robust Statistics

N/A

N/A

N/A

N/A

Five Factor Solution
Maximum Likelihood Statistics

N/A

N/A

N/A

N/A

Hierarchical Factor Solution
Robust Statistics

40

95.18***

.975

.057 (.04, .07)

Hierarchical Factor Solution
Maximum Likelihood Statistics

40

114 9***

.970

.066 (.05, .08)

Single Factor Solution
Robust Statistics

Note. Df = degrees of freedom; x2 = Chi-Square; CFI = comparative fit index; RMSEA
root-mean-square error of approximation; Cl = confidence interval.
p<.001
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Model 1. After running the hypothesized CFA, the Satorra-Bentler scaled Chisquare, CFI, and RMSEA illustrated a poor fitting model, x2(44 A=430) = 475.89,;? <
.001, CFI=.802, RMSEA=.151, Cl (.139,. 163). The Satorra-Bentler scaled Chi-square
had a ratio of almost 11:1, well above the expected 3:1 ratio, and the RMSEA of. 151
being significantly higher than the .10 which Kline (2005) finds the minimum to qualify
as a “good” model. The standardized path coefficients for all parcels were above .5 with
the exception parcel 8 (Floral Scents) and parcel 9 (Industrial Scents) which were at .42
and .31 respectively. Additionally their proportion of variance explained were not
meaningfully high (parcel 8 = .176 and parcel 9 .098). All other parcels explained at
minimum .333 of the variance. Taken together, both the model fit indices, as well as
item-level coefficients, indicate a poorly fitting model. Figure 4 displays the item
loadings visually on each factor as hypothesized.
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Figure 4. Single Factor Solution

Model 2. When the Five Factor Model was placed into EQS, the program would
not allow the model to run, stating instead that factor 5 (Psychosomatic Complaints) was
linearly dependent on other parameters. As stated by Rentier and Chou (1987), linear
dependencies often reflect redundancies among different variables thereby implying a
singular matrix. In essence the problem is one of multicollinearity. The correlations
between the different factors are so strong that it becomes nearly impossible to
differentiate them. As it relates to this study, the Five Factor model was configured (each
factor was discrete with no overlap) in such a way that it did not allow the program to run
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without an error. Consequently, the Five Factor model does not fit and the data does not
support this model.
Model 3. The third model with Gulf War Illness as a second order factor,
demonstrates a strong fit overall. The CFI, and RMSEA exceed the minimum standards
previously stated with a CFI=.975 and an RMSEA=.057, Cl (.042,.071). Although the fit
indices for the model using robust statistics are indeed better, the differences appear to be
minimal with the non robust ML Goodness of Fit on the CFI=.970 and the RMSEA=.066,
Cl (.052,.080). Consequently it is possible the data did not deviate as significantly from
normality as previously thought. Due to the minimal differences between the robust and
ML, all reported statistics in Figure 5 are those from the Maximum Likelihood model
estimation. Additionally, the Chi-Square remains below a 3:1 ratio (x2 = 2.9:1) and falls
within acceptable limits. The Goodness of Fit indices support an omnibus fit for the
model, as do the correlations between items, 1st order factors, and the 2nd order factor of
Gulf War Illness. The standardized solution indicates strong relationships between the
item-level and 1st order factors with correlations ranging from .652 to .958. Additionally
the correlations between the 1st order factors and the 2nd order factor of GWI also
evidenced moderate to strong correlations of .423 to .991. Given the results it appears
Model 3 fits the data both at an omnibus and item level.
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Discussion

The overall aim of this study was to determine whether symptoms experienced by
veterans of the first Persian Gulf War were better explained as individual medically
unexplained illnesses (e.g., fibromyalgia, IBS, CFS, MCS, and psychosomatic
complaints) or by a unified concept of Gulf War Illness. Results indicate symptoms are
best accounted for through Gulf War Illness as a unifying concept along with distinct
medically unexplained illnesses. Unlike many previous studies involving Gulf War
Syndrome and medically unexplained illnesses (e.g., Ismail & Lewis, 2006), this study
found symptoms as manifested in Gulf War veterans were perhaps better explained a
Gulf War Illness construct as evidenced by a slightly better omnibus fit. Ismail and
Lewis (2006) go on to note the extreme paucity of literature examining Gulf War
veterans and their symptomology utilizing complex statistical methods such as
exploratory factor analysis much less when utilizing a confirmatory factor analysis.
According to the authors of that article they were only able to find one such study that
found that symptoms measured in Gulf veterans fitted well in the non-Gulf veteran
population as well. Brown in 2004 proposed that while different theories can account for
certain features of medically unexplained illnesses, no one theory can account for all the
available evidence involving those conditions. In a study looking at overlapping
conditions among patients with different medically unexplained illnesses Aaron, Burke,
& Buchwald (2000), found evidence that patients with chronic fatigue syndrome and
fibromyalgia, and temporomandibular disorder shared key symptoms. As with Brown’s
study, this study found that symptoms endorsed by military personnel in the Gulf War
Veterans Health Questionnaire shared many key similarities. Regardless of whether GWI
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exists as a separate medically unexplained illness or whether it simply is a
conglomeration of key symptoms shared by multiple MUI’s, treatment of those
symptoms is of utmost importance.

Treatment Options
Gulf War Illness. Currently very few treatment options exist for individuals
diagnosed with Gulf War illness. In a summary of treatments for GWI presented by the
United States Department of Veterans Affairs from 2007, the VA noted that $20 million
dollars was being invested into developing treatment options for GWI. Trials in
cognitive behavioral therapy (CBT), exercise/behavioral therapy, and the use of
doxycycling (an antibiotic) are all currently being studied for efficacy (VA Research and
Development, 2007). In an article detailing a randomized controlled trial of CBT and
aerobic exercise in Gulf War veterans, Donta et al. (2003) found that CBT and/or
exercise can provide modest relief for chronic multisymptom illnesses, of which Gulf
War Veteran’s Illness is one. Of note in the previous study is that the CBT and exercise
methodology was taken from treatment models developed for civilians with symptoms
consistent with chronic fatigue syndrome (Hotopf, 2003). Given the nebulous state of
treatment options available for GWI, it may be beneficial to look at treatment options for
the distinct MUI that might make up GWI.
Treatment options for individuals with medically unexplained illnesses have
developed over time and take into account not only treatment of physical complaints but
also psychological complaints. As treatment options develop, and some have been shown
to have promise, the effect sizes are relatively small (Allen, Escobar, Lehrer, Gara, &
Woolfolk, 2002). Some treatment options are relatively similar between different
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medically unexplained illnesses (i.e., Cognitive Behavior Therapy) while others are very
unique to the particular diagnosis.
Somatoform Disorder. Similar to Gulf War Illness, treatment options for
Somatoform Disorder, are not fully researched. As with other functional somatic
symptoms or medically unexplained illnesses, Cognitive Behavior Therapy has been
found to be most efficacious (Looper & Kirmayer, 2002, Kroenke, 2007, Sumathipala,
2007). Additionally, in a review of randomized controlled trials, researchers found that
while the use of antidepressants was effective functional somatic syndromes, it was not
clearly effective for somatoform disorders (Kroenke, 2007). Of interest as well in the
study by Kroenke was that a psychiatric consultation letter sent to the patient’s primary
care physician was also found to be an effective intervention although he notes this is
mostly seen in terms of reducing cost, and not necessarily in treating the somatic
symptoms themselves.
Chronic Fatigue Syndrome. In Chronic Fatigue Syndrome, treatment options
can be placed into one of five categories: pharmacologic, nutritional supplement,
behavioral, immunotherapy, and new therapies. In a review of possible treatment options
for CFS, Erdman (2003) looked at the literature on numerous randomized controlled
trials (RCT) that have been conducted to find treatments for CFS. What she found was
that most RCTs were had a small number of participants, with the average number of
participants at fewer than 70. Additionally there appeared to be no unified outcome
measure used, making it difficult to compare trials for efficacy. Given those limitations,
the most effective therapeutic interventions for CFS include behavioral treatments,
cognitive behavioral therapy, and a graded exercise program. Pharmacological
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interventions such as Hydrocortisone, NADH, EFAs, and IgG do have some positive
effects but the data remains inconclusive as to the level of benefit. Indeed, like in
Erdman’s study, Prins, van der Meer, and Bleijenberg (2006) also found a consensus in
the literature with both CBT and graded exercise being the only interventions found to be
beneficial. While CBT might teach patients with CFS how to get and maintain control
over their symptoms, graded exercise is based primarily on a physiological model of
deconditioning. Graded exercise therapy does not focus on and treat cognitions although
some studies have modified graded exercise therapy to include encouraging thoughts
while exercising. The authors note that while CBT is a more complex therapeutic
approach to CFS than graded exercise therapy, both are effective with more than half the
patients who receive treatment. While many benefit for CBT or graded exercise therapy
to relieve their symptoms of CFS, not all do. Predictors of poor treatment outcome
include: membership in a self-help group, disability reimbursements, low sense of
control, pervasive passive activity patterns, and a low sense of control (Prins, van der
Meer, & Bleijenberg, 2006)
Hammond (2001) followed a single patient with CFS and provided treatment
through neurofeedback with self-hypnosis. The study found that a treatment approach
utilizing both EEG neurofeedback and self-hypnosis training led to considerable
improvement for the subject in fatigue, vigor, and confusion with most changes
maintained, even through a 9-month follow-up.
Irritable Bowel Syndrome. As with Chronic Fatigue Syndrome, Irritable Bowel
Syndrome (IBS) has many different treatment strategies including both conventional and
alternative. Treatments other than CBT or medication exist and are somewhat prevalent
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in the management of IBS. In a systematic review of both complementary and alternative
medicines used in treating IBS, Hussain and Quigley (2006) found evidence to support
treatment through hypnotherapy, herbal therapy, and certain probiotics. Recently the use
of complementary and alternative medicines (CAM) has increased quite rapidly. In a
study looking at the use of CAM in the United States for medical benefit, the authors
found utilization of alternative therapies had increased from 25% to 42% of the entire
population in the years between 1990 and 1997 (Eisenberg, David, Ettner, et al., 1998).
As they relate to IBS, CAMs include reflexology, hypnotherapy, traditional Chinese
medicines, herbs, oils, dietary modifications, probiotics, and determining food
sensitivities. Of all the different manipulatives and body-based treatments available for
IBS, hypnosis appears to be the most efficacious. Tan, Hammond, and Joseph (2005) in
a review of 14 studies on the efficacy of hypnosis found that hypnotherapy consistently
produced results which generally improved the symptoms of IBS in a majority of
patients. The authors also offer a cautionary note by stating that due to the high placebo
response rate in IBS studies, it may be speculated that CAM in and of itself is a new
placebo. In addition to CAM treatments for IBS, psychological treatments have also
been found to be effective (Drossman & Thomspon, 1992). Kraft and Kraft (2007)
explored symptomatic treatments versus integrative psychotherapy including
antispasmodics, antidepressants, antidiarrheal agents, serotonergic modifying drugs, diet
control, peppermint oil, prebiotics, and probiotics. Additionally the authors noted that the
use of medical and dietary modifications are generally first line treatments in the
Manchester Model. The Manchester Model has now become the standard approach for
treatment of IBS. The model consists of 7 to 12 sessions of hypnotherapy with each
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session lasting between 30-60 minutes in length. Furthermore the treatment involves
induction, deepening, guided imagery, use of metaphors, and hand warmth on the
abdomen (Gonsalkorale, 2006). Beyond the use of psychotherapy, other therapeutic
methods have been found to be effective in treating IBS. In a study comparing CBT to
education and a tri-cyclic antidepressant (desipramine) to a drug placebo, the authors
found CBT to be significantly more effective to education but the active drug was not
superior to the placebo. The study found no differences between CBT and desipramine
(Drossman et al., 2003). Limitations noted were the population studied consisted of only
female and about 80% had IBS.
Fibromyalgia. As with other medically unexplained illnesses, there is no single
modality of treatment for Fibromyalgia that has been found to be most effective (Yousefi
& Coffey, 2005). Current treatment strategies focus on pharmacotherapy including:
analgesics, dopaminergic agents, pregabalin, antidepressants, SSRIs, and SNRIs (Spaeth
& Briley, 2009). As pharmacotherapy alone is rarely a sufficient intervention, integrated
and holistic treatment models offer the most successful outcome for persons with
fibromyalgia (Peterson, 2007). Therapeutic approaches including CBT and exercise,
along with patient education have been shown to be effective. Graded aerobic exercises
such as walking, water aerobics, and stationary bicycle should begin slowly and gradually
become more intensive given that many patients in trials involving exercise quit due to
pain or fatigue (Waxman, 2005). Studies have found that short-term cognitive behavioral
therapy has been found to improve pain, fatigue, mood, and function in patients with
Fibromyalgia up to 12 months after intervention (Williams, 2003; Thieme, Flor, & Turk,
2006). It is important to note that especially with fibromyalgia, no single treatment will
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reliably control symptoms in all patients. Consequently a multidimensional approach is
highly recommended (Huynh et al., 2008).
Multiple Chemical Sensitivity. Unlike other, more established, medically
unexplained illnesses, Multiple Chemical Sensitivity lacks a widely accepted treatment
protocol. Due to the paucity of information regarding MCS, treatment options are
limited. In a study looking at perceived treatment efficacy for people with multiple
chemical sensitivity, Gibson, Elms & Ruding, (2003), found that participants had
consulted an average of 12 health care providers but only found an average of 3 to be
helpful. Additionally participants had used an average of 31 treatments including
nutritional supplements, environmental medicine techniques, holistic therapies, body
therapies, prescription items, detoxification processes, and other methods to try and
manage their symptoms. The study found the three most effective treatments included;
creating a chemical-free living space, chemical avoidance, and prayer, none of which
involve traditional or even alternative treatment strategies. Additionally these
interventions were generally non-invasive and low risk.

Conclusion
In summary, the current data from the Gulf War Veterans Health Questionnaire
(GWVHQ) would seem to support the existence of GWI as a second order factor that
takes into account symptoms from CFS, IBS, FMS, MCS, and psychosomatic
complaints. Additionally the data does not support a conceptualized model that does not
include GWI but, instead accounts for the symptoms according to the individual MUI
(e.g., CFS, IBS, etc.). In the opinion of this examiner, future considerations should focus
on treatment options for Gulf War Illness and given its complexity perhaps the answer is
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to look at treatment on a symptom level. Regardless of whether or not Gulf War Illness
is indeed comprised of distinct medically unexplained illnesses, the treatments remain
similar and may be equally effective.
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